WT1 and acute myeloid leukemia: In line with the lower bone marrow blast percentage, the WT1 transcript burden in the bone marrow was significantly lower in the BCL-2− AML subgroup (47,910 ± 24,410 copies/μg) as compared with the BCL-2+ subgroup (148,900 ± 23,700 copies/μg; p = 0.0016) (Figure 2).